FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 44 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $826 | -14.9% | 110 | 0.0% | 0.00% | – |
| Q2 2023 | $971 | -96.2% | 110 | -96.4% | 0.00% | – |
| Q1 2023 | $25,459 | -31.2% | 3,060 | -21.4% | 0.00% | – |
| Q4 2022 | $37,000 | -58.9% | 3,892 | -65.0% | 0.00% | – |
| Q3 2022 | $90,000 | +42.9% | 11,110 | -1.0% | 0.00% | – |
| Q2 2022 | $63,000 | 0.0% | 11,220 | 0.0% | 0.00% | – |
| Q1 2022 | $63,000 | +31.2% | 11,220 | +2.3% | 0.00% | – |
| Q4 2021 | $48,000 | -59.0% | 10,970 | -11.3% | 0.00% | – |
| Q3 2021 | $117,000 | +30.0% | 12,370 | 0.0% | 0.00% | – |
| Q2 2021 | $90,000 | +429.4% | 12,370 | +359.9% | 0.00% | – |
| Q1 2021 | $17,000 | – | 2,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |